Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients

Acosta, Manuel Barreiro‐de; Marín-Jiménez, Ignacio; Panadero, Abel; Guardiola, Jordi; Cañas, Mercedes; Montoya, Milena Gobbo; Modino, Yolanda; Alcaín, Guillermo; Boscá-Watts, Marta Maia; Calvet, Xavier; Casellas, Francesc; Chaparro, María; Salazar, Luis Fernández; Ferreiro-Iglesias, Rocío; Ginard, Daniel; Iborra, Marisa; Manceñido, Noemí; Mañosa, Míriam; Merino, Olga; Rivero, Montserrat; Roncero, Óscar; Sempere, Laura; Vega, Pablo; Zabana, Yamile; Mínguez, Miguel; Nos, Pilar; Gisbert, Javier P.

doi:10.1016/j.gastre.2017.10.013

Cited by 8 publications

(8 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the importance of this problem, GETECCU published a document with recommendations for managing psychological problems in IBD patients, highlighting the importance of early detection of anxiety and depression. 22 …”

Section: Discussionmentioning

confidence: 99%

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

Camba

Ramos²,

Álvarez³

et al. 2022

Gastroenterología y Hepatología (English Edition)

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

Camba

Ramos²,

Álvarez³

et al. 2022

Gastroenterología y Hepatología (English Edition)

View full text Add to dashboard Cite

“…The etiology of ulcerative colitis is still unknown. However, most studies believe that psychological factors play an important role in the occurrence and development of ulcerative colitis [36,37]. Previously publications demonstrated that depression or anxiety was significantly improved after colectomy [38,39].…”

Section: Discussionmentioning

confidence: 99%

Correlation between serum homocysteine level and ulcerative colitis: A meta-analysis

et al. 2019

View full text Add to dashboard Cite

Background: The aim of the present meta-analysis was to investigate the correlation of serum homocysteine (Hcy) concentration and ulcerative colitis (UC) through pooling all the relevant publications. Methods The electronic databases of PubMed, EMBase, Web of Science, Google Scholar, CBM, and CNKI were systematic searched with the text words of homocysteine/Hcy, ulcerative colitis/UC, and inflammatory bowel disease. The correlation between serum Hcy and UC were demonstrated by stand mean difference (SMD) and corresponding 95% confidence interval (95% CI). The publication bias was evaluated by Egger’s line regression test and Begg’s funnel plot. Results After systematic searching the related electronic databases of PubMed, EMBase, Web of Science, Google Scholar, CBM, and CNKI, eighteen publications relevant to serum Hcy and UC were included in the present meta-analysis. The serum Hcy leves were 14.01±2.76 and 10.31±1.59 μmol/L for UC groups and healthy controls respectively with statistical difference (p<0.05). Significant heterogeneity was found (I2=94.5%, p<0.001) among the included studies. Therefore, the SMD was pooled through the random effect model. The pooled SMD was 1.20 (95% CI: 0.89-1.51), indicating that serum Hcy levels were significant higher in UC groups compared to healthy controls with statistical difference (Z=7.52, P<0.001). Egger’s line regression test indicated no publications bias (t=1.45, p=0.17). Conclusion: Serum Hcy levels were usually elevated in UC patients, which indicates that Hcy may play an important role in UC development and may be used as a serological biomarker for UC diagnosis.

show abstract

“…Unexpectedly, active disease has been associated with greater problems in sexual functioning [31] . The negative impact of IBD on sexual health was further highlighted by a Spanish Working Group which recommended that in managing patients with IBD, its burden should be actively explored [32] .…”

Section: Impact Of Ulcerative Colitis On Quality Of Lifementioning

confidence: 99%

Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review

Armuzzi

Liguori

2021

Digestive and Liver Disease

View full text Add to dashboard Cite

As a chronic inflammatory disease, ulcerative colitis has significant negative impact on the quality of life (QoL) of patients. Since the disease affects many aspects of QoL, comprising multiple domains, treatments that induce and maintain remission can provide benefits beyond hard clinical endpoints. Effective treatment of ulcerative colitis can restore QoL and return it to normal or near normal levels. Biological therapies have shown consistent improvement in the QoL of patients with ulcerative colitis during the induction phase, with benefits that are generally maintained in the long-term. Current medical treatment options broadly comprise aminosalicylates, corticosteroids, thiopurines, and calcineurin inhibitors, as well as biologic therapies. Conventional therapies do not always adequately control disease in a sizeable portion of patients, while anti-TNF antibodies are associated with several issues such as contraindications, intolerance, primary non-response, and loss of response in some patients. JAK inhibitors have been associated with clinical improvements in disease manifestations and long-term improvement in QoL outcomes. However, additional studies are needed to better understand the comparative effects of different treatments on QoL and patient preferences for therapy. Herein, the available evidence is reviewed regarding the impact of various treatments on QoL in patients with moderate to severe ulcerative colitis.

show abstract

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients

Cited by 8 publications

References 26 publications

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection

Correlation between serum homocysteine level and ulcerative colitis: A meta-analysis

Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review

Contact Info

Product

Resources

About